GFR decline and mortality risk among patients with chronic kidney disease.
about
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease.Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients.P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease.Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.Short-term change in eGFR and risk of cardiovascular events.Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United StatesChange in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and MortalityEpidemiology of CKD Regression in Patients under Nephrology Care.Rate of change in renal function and mortality in elderly treated hypertensive patients.Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death.Early chronic kidney disease: diagnosis, management and models of carePsychosocial stress and changes in estimated glomerular filtration rate among adults with diabetes mellitus.Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD.Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan.Association of Slopes of Estimated Glomerular Filtration Rate With Post-End-Stage Renal Disease Mortality in Patients With Advanced Chronic Kidney Disease Transitioning to Dialysis.Change in Measured GFR Versus eGFR and CKD Outcomes.Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.Analysis of factors predicting mortality of new patients commencing renal replacement therapy 10 years of follow-up.Age and association of kidney measures with mortality and end-stage renal disease.Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4.Nondialysis chronic kidney disease in 2011: Progression, prediction, populations and possibilities.Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.The Chronic Kidney Disease Water Intake Trial: Protocol of a Randomized Controlled TrialStage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question.Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.Renal function trajectory over time and adverse clinical outcomes.Past Decline Versus Current eGFR and Subsequent ESRD Risk.Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.Risk of ESRD and Mortality Associated With Change in Filtration Markers.Pre-dialysis decline of measured glomerular filtration rate but not serum creatinine-based estimated glomerular filtration rate is a risk factor for mortality on dialysis.Past Decline Versus Current eGFR and Subsequent Mortality RiskThe impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation.Chronic kidney disease progression is mainly associated with non-recovery of acute kidney injury.Improvement in kidney function: a real occurrence.Late acceleration of glomerular filtration rate decline is a risk for hemodialysis catheter use in patients with established nephrology chronic kidney disease care.The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications.Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases.Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria.One-year change in kidney function is associated with an increased mortality risk.
P2860
Q33721299-DC480B0F-8D3A-4172-8DC7-1F9DC540B072Q33862914-3029BE7D-1F15-4B5F-AA36-863ADF01DB62Q33869113-BF8C4F6E-EB30-43C7-B76E-F62F9A86EB0FQ33875330-8059A7F3-9EAF-4166-A93A-1D0A5A3AF009Q34231098-6A109F73-B21B-4A50-A158-465509C07DC9Q35070624-2D38C14D-B382-4E14-8E30-0875B2CA35DDQ35602139-EAEEED2D-006D-495F-B0A9-DAFEFD9ACE92Q35682230-FD569BDD-FD17-433B-A6AA-6FF8E425104DQ35804954-DCB02D46-7EBD-4418-B352-E703A82CAF71Q35817018-29839EC9-EFC7-42CC-A30D-F1889974B49DQ35930343-0475D834-20F7-4269-9D1D-1E193BDED949Q35938045-38DB434D-B6F0-4AD2-BE35-4662C2FEB794Q36171169-EC9A9B3B-AB2C-444F-815B-927307B55256Q36250310-974523D6-9B05-42EC-A9BE-5C9A27869C43Q36336062-AD72B53B-B133-43CB-AEB7-49E0EA3EDDFEQ36565506-7A3FCB88-4FF6-40B2-B23C-03C3BB46A89DQ37051996-B105D608-768C-48A4-9AC7-4B39F740B65BQ37334515-A9A4151E-E2AF-470A-B6A9-0C7649D1CB39Q37516975-1C6F0E67-613E-430B-9864-E3EF8F3A7DDCQ37606084-F4CA0410-CDDB-471C-9CFC-DA890EA5D8C4Q37640240-63A92480-B8BE-4131-BEB9-DD9B4B3FF571Q37964975-B7EDAA5E-07BB-4588-9B4C-D6A11AC252D3Q38018816-A7844FB0-C401-4757-9604-45E4A354387EQ38371440-1136BE3F-AD40-4043-A8A6-FFFFD550C1E3Q38638777-53BD9DB8-AC65-46A8-93E6-7208BA5B6A4DQ38656498-77A53682-27D9-4425-91F5-64C970B38AE7Q38686233-EA3FF22C-54BF-4F92-8714-CCA6583803B2Q38932942-8077277D-E63C-41BF-9E29-F79CD4C8B991Q39131828-3A972DDA-507C-41D7-B25B-921AB9303313Q40146334-DAB1BFBC-9D76-4A63-9E73-91B16D2F7647Q40696578-EFFAE370-A81E-486D-92DA-6C6E18C64081Q41058495-23022A24-C020-447B-8147-D3D1399CE283Q41115247-66D06291-A6A8-42C0-A2D1-07A4F71E6230Q41380210-5E492293-FE17-4468-9AC6-67807733CFE3Q42566428-9A9F72B0-C9AA-4E10-A022-FFF33F64D71FQ46008348-D8E236DB-DA8B-4FD9-8A31-ADD8E4147FF8Q47648986-0E6C5946-698D-4294-9141-73B17B45A8E5Q48775031-4CB2531A-6270-4DB0-9527-5183FDD255E3Q51248518-F7174F41-D0FC-405A-BB9E-1CFEA6577CCCQ51331997-A94E97D6-E63C-472D-88E1-161B57748048
P2860
GFR decline and mortality risk among patients with chronic kidney disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
GFR decline and mortality risk among patients with chronic kidney disease.
@ast
GFR decline and mortality risk among patients with chronic kidney disease.
@en
type
label
GFR decline and mortality risk among patients with chronic kidney disease.
@ast
GFR decline and mortality risk among patients with chronic kidney disease.
@en
prefLabel
GFR decline and mortality risk among patients with chronic kidney disease.
@ast
GFR decline and mortality risk among patients with chronic kidney disease.
@en
P2093
P2860
P356
P1476
GFR decline and mortality risk among patients with chronic kidney disease.
@en
P2093
H Lester Kirchner
Ion D Bucaloiu
James E Hartle
Nasrin Ashouian
Robert M Perkins
Taher Yahya
P2860
P304
P356
10.2215/CJN.00470111
P577
2011-06-16T00:00:00Z